2008•Lishizhen Medicine and Materia Medica ResearchRequires access

Pharmacokinetic Study of Schisandrin in Shengmai Powders

Zehua Hu

Open publisher page 0 citations

Abstract

Objective To study the pharmacokinetics of schizandrin in Shengmai powders in normal rats.MethodsAfter ig administration of the drug(2.16 g/kg)for the rats,the plasma was collected at different time points.The schizandrin in Shengmai powders and in the plasma were analyzed by HPLC.Pharmaconetic parameters were calculated from the plasma concentration-time data with the 3p97 software package.ResultsThe main pharmacokinetic parameters were as follows:t1/2(Ka) was 0.245 hour,t1/2(Ke) was 1.506 hour,T(peak) was 0.767 hour,Cmax was 0.926 mg·L-1,AUC was 2.863 mg·L-1·h-1.ConclusionThe schizandrin in Shengmai powders can be absorbed into body,and its absorption and elimination is rapid.The pharmaconetics of plasma schizandrin complies with linear kinetic course.

About this research paper

What this paper is about

Objective To study the pharmacokinetics of schizandrin in Shengmai powders in normal rats.MethodsAfter ig administration of the drug(2.16 g/kg)for the rats,the plasma was collected at different time points.The schizandrin in Shengmai powders and in the plasma were analyzed by HPLC.Pharmaconetic parameters were calculated from the plasma concentration-time data with the 3p97 software package.ResultsThe main pharmacokinetic parameters were as follows:t1/2(Ka) was 0.245 hour,t1/2(Ke) was 1.506 hour,T(peak) was 0.767 hour,Cmax was 0.926 mg·L-1,AUC was 2.863 mg·L-1·h-1.ConclusionThe schizandrin in Shengmai powders can be absorbed into body,and its absorption and elimination is rapid.The pharmaconetics of plasma schizandrin complies with linear kinetic course.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the pharmacokinetics of schizandrin in Shengmai powders in normal rats.MethodsAfter ig administration of the drug(2.16 g/kg)for the rats,the plasma was collected at different time points.The schizandrin in Shengmai powders and in the plasma were analyzed by HPLC.Pharmaconetic parameters were calculated from the plasma concentration-time data with the 3p97 software package.ResultsThe main pharmacokinetic parameters were as follows:t1/2(Ka) was 0.245 hour,t1/2(Ke) was 1.506 hour,T(peak) was 0.767 hour,Cmax was 0.926 mg·L-1,AUC was 2.863 mg·L-1·h-1.ConclusionThe schizandrin in Shengmai powders can be absorbed into body,and its absorption and elimination is rapid.The pharmaconetics of plasma schizandrin complies with linear kinetic course.

Key concepts: Cmax, Pharmacokinetics, Chemistry, Plasma concentration, Pharmacology, High-performance liquid chromatography, Absorption (acoustics), Plasma levels

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetic Study of Schisandrin in Shengmai Powders — Research Paper | ScholarLens